Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Apyx Medical (APYX) over the last 15 years, with Q3 2025 value amounting to -$4.0 million.

  • Apyx Medical's Net Cash Flow rose 1278.82% to -$4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year decrease of 14441.64%. This contributed to the annual value of -$12.0 million for FY2024, which is 13573.15% down from last year.
  • As of Q3 2025, Apyx Medical's Net Cash Flow stood at -$4.0 million, which was up 1278.82% from -$1.5 million recorded in Q2 2025.
  • Apyx Medical's 5-year Net Cash Flow high stood at $21.5 million for Q4 2023, and its period low was -$6.4 million during Q1 2024.
  • Over the past 5 years, Apyx Medical's median Net Cash Flow value was -$3.8 million (recorded in 2021), while the average stood at -$884684.2.
  • In the last 5 years, Apyx Medical's Net Cash Flow crashed by 288216.56% in 2022 and then surged by 56003.84% in 2023.
  • Apyx Medical's Net Cash Flow (Quarter) stood at -$157000.0 in 2021, then crashed by 2882.17% to -$4.7 million in 2022, then surged by 560.04% to $21.5 million in 2023, then crashed by 83.39% to $3.6 million in 2024, then crashed by 212.07% to -$4.0 million in 2025.
  • Its Net Cash Flow stands at -$4.0 million for Q3 2025, versus -$1.5 million for Q2 2025 and -$732000.0 for Q1 2025.